Post on 22-Dec-2015
Accessing Global Healthcare: The Role of Innovation
The International Economic Forum of the AmericasPalm Beach, April 7, 2014
Murray Aitken, Executive Director
Palm Beach Strategic Forum 040714
TRANSFORMATIVE INNOVATION ACROSS HEALTHCARE
Predisposition
WellnessDiagnosis Therapy
Rehabilitation
Monitoring
IntegratedHealthcare
In vitro diagnostics
Genomics
In vivo diagnosticsMedical devices
Pharmacotherapy
Regenerative/tissueengineering
RemoteMonitoring/Telemedicine
Surgery
Behavioraldiagnostics
2
Informatics
Palm Beach Strategic Forum 0407143
2010 2011 2012 Average Per Year 2013-
2017
0
5
10
15
20
25
30
35
40
Novel Mechanism Existing Mechanism Orphan
GLOBAL LAUNCHES OF NEW MOLECULAR ENTITIES
Source: IMS Institute for Healthcare Informatics, October 2013
GLO
BA
L N
ME L
AU
NC
HES
New therapy options:
Rheumatoid arthritisCystic fibrosisMelanomaBreast cancerOvarian cancerMultiple sclerosisHeart failureHepatitis CMalariaMany rare diseasesEtc.
ESTIMATED TOTAL SPENDING ON MEDICINES IN 2014
Palm Beach Strategic Forum 040714
$1 Trillion
4
North America$373 Bn
Central & Latin
America$80 Bn
Africa
$23 Bn
Europe & CIS
$253 Bn
Asia & Oceania$270 Bn
Middle East
$18 Bn
5
ANNUAL AVOIDABLE HEALTHCARE COSTS DUE TO MEDICINES NOT BEING USED RESPONSIBLY
Palm Beach Strategic Forum 040714
Medication nonadherence
Delayed evidence-based treatment
Medication errors
Suboptimal generics use
Mismanaged polypharmacy
Antibiotic misuse
$269 Bn
$62 Bn
$54 Bn
$42 Bn
$30 Bn
$18 Bn
Total Annual
Avoidable Costs:
$475 Bn = ~8% THE
Global 2012
PRIORITIES FOR LEVERAGING INNOVATION TO ADVANCE GLOBAL HEALTHCARE
Palm Beach Strategic Forum 0407146
Creating or sustaining the eco-system to support innovation
Using common language, common metrics to set goals and measure progress
Applying rigorous assessment of clinical benefits from innovation
Leveraging digitized information
Balancing equity and affordability